Preprandial ghrelin is not affected by macronutrient intake, energy intake or energy expenditure
Journal of Negative Results in BioMedicine volume 4, Article number: 2 (2005)
Ghrelin, a peptide secreted by endocrine cells in the gastrointestinal tract, is a hormone purported to have a significant effect on food intake and energy balance in humans. The influence of factors related to energy balance on ghrelin, such as daily energy expenditure, energy intake, and macronutrient intake, have not been reported. Secondly, the effect of ghrelin on food intake has not been quantified under free-living conditions over a prolonged period of time. To investigate these effects, 12 men were provided with an ad libitum cafeteria-style diet for 16 weeks. The macronutrient composition of the diets were covertly modified with drinks containing 2.1 MJ of predominantly carbohydrate (Hi-CHO), protein (Hi-PRO), or fat (Hi-FAT). Total energy expenditure was measured for seven days on two separate occasions (doubly labeled water and physical activity logs).
Preprandial ghrelin concentrations were not affected by macronutrient intake, energy expenditure or energy intake (all P > 0.05). In turn, daily energy intake was significantly influenced by energy expenditure, but not ghrelin.
Preprandial ghrelin does not appear to be influenced by macronutrient composition, energy intake, or energy expenditure. Similarly, ghrelin does not appear to affect acute or chronic energy intake under free-living conditions.
Ghrelin, a peptide secreted by endocrine cells in the gastrointestinal tract, is thought to play a significant role in the regulation of energy balance due to its effects on the stimulation of food intake [1, 2] and weight gain [1–3] in rodents. It has been suggested that ghrelin may also play a role in meal initiation in humans, since the concentration of ghrelin increases immediately prior to a meal  and decreases after eating [4–6]. Furthermore, ghrelin infusions are associated with feelings of hunger and increased energy intake during a buffet-style lunch .
Despite the evidence indicating a role in acute food intake, little is known about the factors regulating ghrelin and its effects on long-term energy balance in humans. One hypothesis is that ghrelin secretion is up-regulated in periods of negative energy balance and down-regulated in periods of positive energy balance . Since energy balance is a function of both energy intake and expenditure, ghrelin concentrations should increase or decrease with fluctuations in food intake (macronutrient composition and/or energy intake) and/or energy expenditure. In turn, increased ghrelin concentrations should be associated with higher food intake. However, the effects of daily fluctuations in food intake and energy expenditure on ghrelin have not been investigated in humans.
The purpose of the present study was to determine how changes in macronutrient composition, energy intake, and energy expenditure affect preprandial ghrelin concentrations, and ghrelin's subsequent effects on food intake.
Body weight and composition
Ghrelin was negatively related to body fat percentage (r = -0.46, P < 0.05) and BMI (r = -0.18, P < 0.02), but not body weight (r = -0.16, P > 0.45). There were no significant body weight changes during the seven day observation periods (2)(data not shown, P > 0.40).
Effect of treatment on macronutrient and energy intake
The composition of the treatment beverages and their contribution to daily food intake is listed in Table 1. Overall, macronutrient intake during the seven day observation periods was primarily determined by the composition of the treatment beverages (Table 2).
Energy expenditure and macronutrient intake effects on preprandial ghrelin
Average 24 hour energy expenditure (24EE; uncorrected activity log alone) was 13.9 ± 1.9 MJ/d compared to 12.6 ± 1.6 MJ/d for total energy expenditure (TEE; doubly labeled water), which is an average over-reporting of energy expenditure of 11%. Thus, our assumption that subjects would likely misreport energy expenditure and the values would require adjustment was valid.
The mean preprandial ghrelin concentrations during the last week of each treatment period were 2501.4 ± 438.0 pg·mL-1 for Hi-CHO, 2869.5 ± 817.3 pg·mL-1 for Hi-PRO, and 2688.2 ± 755.5 pg·mL-1 for Hi-FAT (Figure 1). These values are higher than reported in similar investigations. This discrepancy is explained by the use of the Linco Research Total Ghrelin RIA kit, which produces values that are approximately 10-fold higher than the most commonly used kit (Phoenix Pharmaceuticals). In a side-by-side comparison, both kits have been found to be analytically acceptable despite the differences in values obtained . Furthermore, the ghrelin concentrations of at least two studies using the same kit were very similar to those we measured [10, 11]. The within- and between-subject coefficients of variation for the two observation periods (seven days per period) were 12.9% and 23.0%, respectively.
Preprandial ghrelin was not influenced by treatment, 24EE, macronutrient composition, and selected (without treatment beverages) and total (including treatment beverages) energy intake (breakfast or entire day), or the interactions between these variables (previous or same day)(all P between 0.40 to 0.80). As a further test, we included energy intake for seven days prior to- and two days after each ghrelin value. None of these days were significant (all P between 0.40 to 0.90). Individual day and mean 24EE up to the prior 4 four days before each ghrelin measurement was also not significant (all P between 0.10 to 0.90).
Effect of ghrelin and energy expenditure on macronutrient and energy intake
Selected and total energy intake for the entire day were significantly influenced by treatment period (P < 0.02), Monday/Friday effect (P < 0.003), Sunday effect (P < 0.03), and 24EE (P < 0.008) (Table 3a). Classifying energy intake into the three macronutrients, the only macronutrient influenced by 24EE was total and selected carbohydrate intake (P < 0.03, and P < 0.02, respectively) (Table 3b). There was no significant effect of ghrelin on total or selected energy intake for breakfast or entire day (all P between 0.80 to 0.90).
The partial correlation between breakfast energy intake and ghrelin was 0.07. At 80% power, we could have detected a ghrelin effect if the true partial correlation was a small as 0.36. For powers of 90% and 95%, the true partial correlations would have had to be 0.40 and 0.43, respectively. The partial correlation between total energy intake and ghrelin was even lower than that with breakfast energy intake (r = 0.003). Note that, for a partial correlation of 0.40, ghrelin would have only been explaining about 16% (0.402) of the variation in energy intake, still a relatively small percentage of explained variation for a hormone purported to exert a large influence on intake.
Of the variables related to energy balance measured in this study (daily macronutrient and energy intake, energy expenditure, and body weight and composition), none appear to play a role in preprandial ghrelin regulation. Similarly, ghrelin did not significantly predict macronutrient or energy intake, despite a power analysis indicating that we would have detected even a moderate effect of ghrelin on intake.
Most of the evidence linking food intake and ghrelin comes from single meal, short-term studies. The ingestion of amino acids or a protein meal results in a post-prandial increase in ghrelin [12–14], whereas high- [14, 15] or moderate carbohydrate [4, 5, 16], and fat  meals decrease ghrelin. Carbohydrate meals may result in a greater post-prandial suppression of ghrelin than fat [16, 17]. However, it has been reported that preprandial ghrelin is unrelated to macronutrient intake in a large (118 subjects) cross-sectional study  and a 12 week longitudinal study . Similarly, three weeks of a high fat diet has been shown to have no effect on fasting ghrelin . Based on the results of the current study and others [18–20], it appears that macronutrient intake does not affect preprandial ghrelin, and any macronutrient-specific effects are limited to the post-prandial period.
Wren et al. were the first investigators to demonstrate that the infusion of ghrelin acutely results in an increase energy intake in humans. The lack of an energy-intake stimulating effect of ghrelin on food intake in the present study when compared to Wren et al. may be related to the amount of ghrelin that was infused (resulting in concentrations twice that under fasted conditions), and the non-free living nature of the subjects. However, other studies have also failed to detect an increase in hunger after ghrelin infusion [21, 22]. Ghrelin concentrations do not predict the timing of a meal request or meal size , and are unaffected by energy-restricted diets [10, 18, 24] and when appetite is increased . Interestingly, it has also been shown that fasting ghrelin is negatively associated with energy intake . In this same study , Caucasians had ghrelin concentrations that were approximately double that of Pima Indians, yet there was no difference in food intake between the groups.
Although body weight typically increases by ≈ 4.5 kg in men and ≈ 7.3 kg in women over the course of 30 years , the human body regulates energy balance rather well (within 1% over the course of 20 years). The strength of the relationship between total energy intake and 24EE measured in this study reflects this regulation, but our data indicate that 24EE does not influence ghrelin. One other study has shown that ghrelin does not appear to be influenced by exercise, regardless of exercise intensity . This longitudinal study (three months) of normal weight young women indicated that ghrelin increases in response to an exercise regimen, but only when exercise induces weight loss. Therefore, it appears that ghrelin is not influenced by changes in energy expenditure alone.
In conclusion, it appears that macronutrient and energy intake, and energy expenditure have no effect on preprandial ghrelin. None of the variables measured in this study explain the high daily variability in preprandial ghrelin observed over the course of two-seven day periods. In turn, this study fails to detect the energy intake-stimulating effect of ghrelin, despite carefully measured food intake that lasted more than a week and a study powered to detect even a moderate effect of ghrelin.
Twelve healthy, non-smoking men were recruited from the Beltsville, MD area to participate in this study (Table 4). All subjects were weight-stable, and not using any medications known to affect food intake, appetite or water balance. The John Hopkins Bloomberg School of Public Health Committee on Human Research approved the study protocol. Subjects provided written informed consent and received a medical evaluation by a physician that included measurement of blood pressure and analysis of fasting blood and urine samples to screen for presence of metabolic disease.
Ad libitum feedings
Voluntary food intake was studied continuously for 16 weeks, whereby subjects consumed only foods provided by the Human Studies Facility (HSF) at the Beltsville Human Nutrition Research Center (BHNRC). Subjects choose foods ad libitum from the menus, and could consume any part or all of a food item, then return the remaining portion to be weighed. BHNRC staff that came into contact with the subjects provided no guidance as to the quantities and/or types of food items chosen. During weekdays, subjects reported to the BHNRC in the morning to eat breakfast, pack selected food items for lunch, then return again in the evening for dinner. Any food taken from the HSF that was subsequently not eaten (all or partial quantities), was returned the next day, and weighed and recorded. On Friday evenings, subjects were provided with coolers packed with a large amount of food for weekend meals. The weekend coolers provided a wide variety of foods in excess quantities, and subjects were allowed to request additional food items be included. Weekend food could be consumed on either day as long as the subjects logged which day each food item was eaten. All uneaten weekend food was returned on Monday, and weighed and recorded. Although subjects were instructed to consume only food items provided by HSF, they were allowed free access to beverages including caloric, noncaloric and alcoholic beverages. Detailed records of the amount, composition and name brand of beverages was submitted daily. In addition to beverages provided on the menu (milk and juice), both regular and decaffeinated coffee and tea were available at meals.
Food items offered in the morning (breakfast and lunch) were presented in a cafeteria-style setting as three different rotating menus, each lasting seven days (Table 5). Some food items remained on all three menus (e.g. milk and orange juice). In the evening, breakfast and lunch items were also available. A typical dinner was presented cafeteria-style as one or two entrée selections with optional gravies or sauces, and a minimum of three vegetables and side dishes. A garden salad with a variety of additional toppings and dressings was also available. Fifteen different dinner menus were rotated daily (Table 5).
The goals of the menu design were to allow detection of macronutrient selection by offering a wide range of carbohydrate, fat- and/or protein-rich foods, and to provide a variety of commonly available foods typical of what many Americans eat. In a research setting it is impossible to duplicate the degree of food choice available in real life. However, more than 300 food items were used to develop menus for this study, and specific requests for food items were incorporated into the menus whenever possible.
Recording and tracking of food intake
After each subject selected his desired foods, he presented them to a staff member that recorded the identity and weight of each food item by hand and on a computer (combination of bar code recognition of the food item and hand-entering of the weight). Upon termination of feeding, each subject presented his tray to a staff member that weighed any uneaten food. The accuracy of the food item recording process was verified by comparing the information on the computer with the hand-entered logs. This verification procedure was followed daily, and repeated at the end of the study with all food records. Energy and macronutrient composition were determined by consultation with the USDA Nutrient Database for Standard Reference .
Covert manipulation of macronutrient composition
During the 16 weeks of ad libitum intake, subjects were randomly assigned to two of three treatments. Each treatment lasted 8 weeks with no break between the periods. The treatments consisted of a daily beverage that contained ≈ 2 MJ/day of predominantly carbohydrate (Hi-CHO), fat (Hi-FAT), or a combination of protein and carbohydrate (Hi-PRO) (Table 1). The daily beverage was divided into three equal portions, and subjects consumed them with each of the three primary meals. The protein drink was designed to provide half the daily Recommended Daily Allowance (RDA)  of protein, with the balance carbohydrate. The drinks were formulated using sucrose, heavy whipping cream, and egg white as the principle source of carbohydrate, fat, and protein, respectively. Water, fat free non-dairy creamer, and aspartame were used to provide volume, adjust texture and add sweetness. Cocoa was added to all drinks to provide a uniform taste and appearance. Subjects were blinded to the treatments and the three drinks were judged to be indistinguishable by a taste panel conducted in our laboratory.
Each morning for the last seven days of each treatment period, subjects reported to the laboratory after a 10–12 hr fast, provided a blood sample, then reported to the HSF to eat breakfast. Blood was collected in tubes containing EDTA, centrifuged, and stored at -80°C until analysis. Plasma ghrelin was analyzed using a commercially available radioimmunoassay kit (Total Ghrelin, Linco Research, Inc.). The intra- and interassay coefficients of variation (CV) were 5.6% and 7.3%, respectively.
Body weight and composition
Before breakfast and after voiding, body weight was determined weekly on an electronic balance to the nearest 0.01 kg. Body composition was measured by Dual-energy X-ray Absorptiometry (DEXA; QDR 4500, Hologic, Inc, Waltham, MA).
Total and 24 hr energy expenditure (24EE)
To "capture" daily variations in energy expenditure, we combined a self-reported activity log  and doubly labeled water measurements. Although doubly labeled water is the "gold standard" measure of free-living energy expenditure, its use is limited by the production of a single value that is assumed to represent average energy expenditure over the course of the dosing period (seven days in this study). This seven day value for energy expenditure is not useful to compare with daily variation in ghrelin and food intake (macronutrient composition and energy intake). Since self-reported measures of energy expenditure (that can provide a daily energy expenditure value) may be misreported by subjects [32, 33], we adjusted the daily numbers using doubly labeled water measurements (see below).
Twenty-four hour energy expenditure (24EE) was estimated using a daily recording log method, modified from Bouchard et al. . Briefly, subjects recorded their daily activities in a log every 15 min over the course of the last seven days of each treatment period. Activities were entered in as a number (1–9), corresponding to example activities listed in the log. Each activity assumed a pre-determined energy expenditure score, thus energy expenditure was calculated as time spent in that activity times the energy expenditure rate.
Total energy expenditure (TEE) was concurrently measured by the doubly labeled water method as described by Speakman , which provided an estimate of energy expenditure during the last seven days of each treatment period. Subjects reported to the BHNRC between 6:30 and 9:00 a.m., at which time they received an oral dose of H2 18O (0.16 g/kg body weight) and 2H2O (0.30 g/kg body weight). Urine samples were collected immediately before the dose and on every morning (second void) for the last seven days of the treatment period. The first sample was collected approximately 24 hr after the dose. Enrichments of 2H and 18O in urine samples were measured by infrared spectroscopy and isotope ratio mass spectrometry, respectively. TEE was calculated using the equations of Weir .
Individual daily 24EE values were corrected using the ratio adjustment (notation denoting subjects is suppressed),
24EEdayx, corrected = 24EEdayx × (TEE/24EEday 1–7), where
24EEdayx is the uncorrected daily energy expenditure value from the activity log for one of the seven days (day X),
TEE is the daily mean energy expenditure estimate using doubly labeled water. Represents a single value during the seven days of measurement (of which 24EEdayx is one), and
24EEday 1–7 is the mean of the seven days of uncorrected 24EE values corresponding to TEE, of which 24EEdayx is one.
To simplify the notation, the 24EEdayx, corrected value for day X will subsequently be referred to as 24EE.
To check the assumption of homogeneous variances necessary for valid F-tests and correct P-values, we used the standard technique of plotting the standard deviations (SD's) against the means for selected energy intake, grouping observations by subject and treatment period. The results of this scatter plot revealed a strong positive linear relationship (r = 0.67, P < 0.001). The relationships between the SD and mean for macronutrient and energy intake (total and selected), and 24EE were also positive and significant. This indicated that the SD's (variances) were a function of the mean and that the data needed to be transformed. We followed methods described by Draper and Smith , and used a family of transformations based on logarithms. For selected energy intake, this transformation was log (b0 + b1yi), where b0 and b1 are the estimated coefficients of the line fit by regressing the SDs on the means, and yi represents the energy intake data. The other variables were transformed using this same family of transformations. This procedure resulted in homogeneous variances for all variables once transformed, satisfying ANOVA assumptions. We present the data on the original scale in tables and figures for ease of interpretation (unless indicated otherwise).
Due to the free-living nature of the subjects, there were three observations (of 168) where (for unknown reasons) a subject's food intake differed greatly from habitual intake due to a skipped meal or meals with low energy intake. For this reason, these observations were not used in the analyses. Additionally, a preliminary sensitivity analysis and residual diagnostics (e.g., restricted likelihood distance, Cook's D; optional output of Proc Mixed, new in version 9.1, in ) suggested they were outliers.
The experimental design was an incomplete block crossover design, with two of the three drink treatments given sequentially to each subject. Data were analyzed in the mixed linear models framework, using the Proc Mixed procedure in SAS (version 9.1). Subject-to-subject variation was modelled as a random effect. Repeatedly measuring each subject over the seven days induced an autoregressive covariance structure we modelled as AR(1). Other design effects we retained in our modelling were a two level period effect ((first 8 week treatment period (1) vs. the second 8 week period (2)), and two day-of-the-week variables, found in a preliminary analysis to account for day-of-the-week effects. Each of these day-of-the-week variables classify days into two groups: (1) Sunday (0 vs. 1 for other days of the week) and (2) Monday/Friday (0 vs. 1 for other days of the week). They allow for the major differences in food intake and energy expenditure due to day-of-the-week effects. Some subject-specific variables, such as body weight, were included as covariates as appropriate. The treatment effects (Hi-CHO, Hi-PRO, and Hi-FAT) were included in all models.
For models predicting ghrelin concentration, we included 24EE, energy intake, and the interaction between 24EE and energy intake. We also considered prior day (up to 7 days) and subsequent day (up to 2 days) values for energy intake and ghrelin, and their interactions as candidate covariates. Values for up to 4 prior days for 24EE were used to predict ghrelin. For models predicting daily energy intake, we included preprandial ghrelin concentrations, 24EE, the interaction between ghrelin and 24EE, and additionally considered as candidate covariates the prior (seven days) and subsequent (two days) days for these two variables and their interactions. We explored models that included other variables and interactions, but none of those variables appeared useful. Data are presented as total intake (intake including treatment drinks) and/or selected intake (intake without treatment drinks). Values are presented as means ± SD unless indicated otherwise.
Since a preliminary analysis suggested that the effect of ghrelin on energy intake was small or negligible, we conducted a power analysis to determine our ability to detect an effect of ghrelin if the effect was small. This was accomplished by Monte-Carlo simulation (creating simulated data sets based on the data we collected) and, starting with no effect of ghrelin (a true coefficient of zero for ghrelin in a regression context), determining how large the true coefficient needed to be to obtain significance for most of the simulations, at powers of 80%, 90%, and 95%, with 1000 simulations for each coefficient value. These results are most easily interpreted as how large a partial correlation between ghrelin and energy intake (adjusting for all other fixed and random effects, other than ghrelin) would be necessary for us to detect it. We conducted this analysis for both total energy intake and breakfast energy intake (the latter was the meal most likely to be influenced by preprandial ghrelin because of the timing of the blood draw).
Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DGA, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000, 141: 4325-4328. 10.1210/en.141.11.4325.
Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR: Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001, 50: 2540-2547.
Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature. 2000, 407: 908-913. 10.1038/35038090.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin level suggests a role in meal initiation in humans. Diabetes. 2001, 50: 1714-1719.
Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C: Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest. 2001, 24: RC19-RC21.
English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JPH: Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab. 2002, 87: 2984-2987. 10.1210/jc.87.6.2984.
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001, 86: 5992-5995. 10.1210/jc.86.12.5992.
Shiiya T, Nakazato M, Mizuta A, Date Y, Mondal MS, Tanaka M, Nozoe SI, Hosada H, Kangawa K, Matsukura S: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002, 87: 240-244. 10.1210/jc.87.1.240.
Groschl M, Uhr M, Kraus T: Evaluation of the comparability of commercial ghrelin assays. Clin Chem. 2004, 2: 457-458. 10.1373/clinchem.2003.025429.
Doucet E, Pomerleau M, Harper ME: Fasting and postprandial total ghrelin remain unchanged after short-term energy restriction. J Clin Endocrinol Metab. 2004, 89: 1727-1732. 10.1210/jc.2003-031459.
Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH: The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors. Eur J Endocrinol. 2004, 150: 715-718. 10.1530/eje.0.1500715.
Groschl M, Knerr I, Topf HG, Schmid P, Rascher W, Rauh M: Endocrine responses to the oral ingestion of a physiological dose of essential amino acids in humans. J Endocrinol. 2003, 179: 237-244. 10.1677/joe.0.1790237.
Knerr I, Groschl M, Rascher W, Rauh M: Endocrine effects of food intake: insulin, ghrelin, and leptin responses to a single bolus of essential amino acids in humans. Ann Nutr Metab. 2003, 47: 312-318. 10.1159/000072405.
Erdmann J, Lippl F, Schusdziarra V: Differential effect of protein and fat on plasma ghrelin levels in man. Regul Pept. 2003, 116: 101-107. 10.1016/S0167-0115(03)00195-2.
Caixas A, Bashore C, Nash W, Pi-Sunyer FX, Laferrere B: Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab. 2002, 87: 1902-1906. 10.1210/jc.87.4.1902.
Greenman Y, Golani N, Gilad S, Yaron M, Limor R, Stern N: Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf). 2004, 60: 382-388. 10.1111/j.1365-2265.2004.01993.x.
Monteleone P, Bencivenga R, Longobardi N, Serritella C, Maj M: Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab. 2003, 88: 5510-5514. 10.1210/jc.2003-030797.
Chan JL, Bullen J, Lee JH, Yiannakouris N, Mantzoros CS: Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab. 2004, 89: 335-343. 10.1210/jc.2003-031412.
Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, Callahan HS, Purnell JQ: Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab. 2003, 88: 1577-1586. 10.1210/jc.2002-021262.
Robertson MD, Henderson RA, Vist GE, Rumsey RDE: Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord. 2004, 28: 727-733. 10.1038/sj.ijo.0802637.
Akamizu T, Takaya K, Irako T, Hosada H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, Yokode M, Tanaka K, Kangawa K: Pharmacokinetics, safety, endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004, 150: 447-455. 10.1530/eje.0.1500447.
Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A: Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab. 2003, 284: E407-15.
Callahan HS, Cummings DE, Pepe MS, Breen PA, Matthys CC, Weigle DS: Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab. 2004, 89: 1319-1324. 10.1210/jc.2003-031267.
Ravussin E, Tschop M, Morales S, Bouchard C, Heiman ML: Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. J Clin Endocrinol Metab. 2001, 86: 4547-4551. 10.1210/jc.86.9.4547.
Salbe AD, Tschop MH, DelParigi A, Venti CA, Tataranni PA: Negative relationship between fasting plasma ghrelin concentrations and ad libitum food intake. J Clin Endocrinol Metab. 2004, 89: 2951-2956. 10.1210/jc.2003-032145.
Kuczmarski RJ: Prevalence of overweight and weight gain in the United States. Am J Clin Nutr. 1992, 55: 495S-502S.
Westerterp KR, Donkers JH, Fredrix EW, Boekhoudt P: Energy intake, physical activity and body weight: a simulation model. Br J Nutr. 1995, 73: 337-347.
Schmidt A, Maier C, Schaller G, Nowotny P, Bayerle-Eder M, Buranyi B, Luger A, Wolzt M: Acute exercise has no effect on ghrelin plasma concentrations. Horm Metab Res. 2004, 36: 174-177. 10.1055/s-2004-814342.
U.S. Department of Agriculture: USDA Nutrient Database for Standard Reference, Release 15. http://www.nal.usda.gov/fnic/foodcomp
National Research Council (U.S.). Subcommittee on the Tenth Edition of the RDAs.: Recommended dietary allowances. 1989, Washington, D.C., National Academy Press
Bouchard C, Tremblay A, Leblanc C, Lortie G, Savard R, Theriault G: A method to assess energy expenditure in children and adults. Am J Clin Nutr. 1983, 37: 461-467.
Kesaniemi YK, Danforth E, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA: Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc. 2001, 33: S351-S358.
Jebb SA, Moore MS: Contribution of a sedentary lifestyle and inactivity to the etiology of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999, 31: S534-S541. 10.1097/00005768-199911001-00008.
Speakman JR: Doubly labelled water: theory and practice. 1997, London, UK, Chapman and Hall, First
Weir JB: New methods for calculating metabolic rate with special reference to protein metabolism. 1949. Nutrition. 1990, 6: 213-221.
Draper NR, Smith H: Applied regression analysis. 1981, N.Y., John Wiley and Sons, 709-2
SAS Institute Inc: . Cary, NC, USA, , 9.1
MK was responsible for statistical analysis and interpretation. DR was responsible for supervising the food intake portion of the study. WR conceived the study, and supervised the data collection and analysis. DP was responsible for ghrelin analysis, data collection, statistical analysis and manuscript preparation. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Paul, D.R., Kramer, M., Rhodes, D.G. et al. Preprandial ghrelin is not affected by macronutrient intake, energy intake or energy expenditure. J Negat Results BioMed 4, 2 (2005). https://doi.org/10.1186/1477-5751-4-2